Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Effects of Intrarenal Nesiritide
NCT00270829Phase 4Terminated
- Sponsor
- University of Maryland, Baltimore
- Start
- Dec 2005
- Primary completion
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in heart failure (HF) comparing Intrarenal Nesiritide with Placebo (2 arms). Primary endpoint: Glomerular Filtration Rate at 6 hours. Started Dec 2005; status: terminated.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00270829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00270829.